TY - JOUR
T1 - Local control and survival after stereotactic radiosurgery for colorectal cancer brain metastases
T2 - an international multicenter analysis
AU - Bin-Alamer, Othman
AU - Abou-Al-Shaar, Hussam
AU - Singh, Raj
AU - Mallela, Arka N.
AU - Legarreta, Andrew
AU - Bowden, Greg
AU - Mathieu, David
AU - Perlow, Haley K.
AU - Palmer, Joshua D.
AU - Elhamdani, Shahed
AU - Shepard, Matthew
AU - Liang, Yun
AU - Nabeel, Ahmed M.
AU - Reda, Wael A.
AU - Tawadros, Sameh R.
AU - Abdelkarim, Khaled
AU - El-Shehaby, Amr M.N.
AU - Eldin, Reem Emad
AU - Elazzazi, Ahmed Hesham
AU - Warnick, Ronald E.
AU - Gozal, Yair M.
AU - Daly, Megan
AU - McShane, Brendan
AU - Addis-Jackson, Marcel
AU - Karthikeyan, Gokul
AU - Smith, Sian
AU - Picozzi, Piero
AU - Franzini, Andrea
AU - Kaisman-Elbaz, Tehila
AU - Yang, Huai Che
AU - Hess, Judith
AU - Templeton, Kelsey
AU - Zhang, Xiaoran
AU - Wei, Zhishuo
AU - Pikis, Stylianos
AU - Mantziaris, Georgios
AU - Simonova, Gabriela
AU - Liscak, Roman
AU - Peker, Selcuk
AU - Samanci, Yavuz
AU - Chiang, Veronica
AU - Kersh, Charles R.
AU - Lee, Cheng Chia
AU - Trifiletti, Daniel M.
AU - Niranjan, Ajay
AU - Hadjipanayis, Constantinos G.
AU - Dade Lunsford, L.
AU - Sheehan, Jason P.
N1 - Publisher Copyright:
©AANS 2024, except where prohibited by US copyright law.
PY - 2024/5/1
Y1 - 2024/5/1
N2 - OBJECTIVE The goal of this study was to characterize local tumor control (LC), overall survival (OS), and safety of stereotactic radiosurgery for colorectal brain metastasis (CRBM). METHODS Ten international institutions participating in the International Radiosurgery Research Foundation provided data for this retrospective case series. This study included 187 patients with CRBM (281 tumors), with a median age of 62 years and 56.7% being male. Most patients (53.5%) had solitary tumors, although 10.7% had > 5 tumors. The median tumor volume was 2.7 cm3 (IQR 0.22–8.1 cm3), and the median margin dose was 20 Gy (IQR 18–22 Gy). RESULTS The 3-year LC and OS rates were 72% and 20%, respectively. Symptomatic adverse radiation effects occurred in 1.6% of patients. In the multivariate analysis, age > 65 years and tumor volume > 4.0 cm3 were significant predictors of tumor progression (hazard ratio [HR] 2.6, 95% CI 1.4–4.9; p = 0.003 and HR 3.4, 95% CI 1.7–6.9; p < 0.001, respectively). Better performance status (Karnofsky Performance Scale score > 80) was associated with a reduced risk of tumor progression (HR 0.38, 95% CI 0.19–0.73; p = 0.004). Patient age > 62 years (HR 1.6, 95% CI 1.1–2.3; p = 0.03) and the presence of active extracranial disease (HR 1.7, 95% CI 1.1–2.4; p = 0.009) were significantly associated with worse OS. CONCLUSIONS Stereotactic radiosurgery offers a high LC rate and a low rate of symptomatic adverse radiation effects for the majority of CRBMs. The OS and LC favored younger patients with high functional performance scores and inactive extracranial disease. https://thejns.org/doi/abs/10.3171/2023.8.JNS231231
AB - OBJECTIVE The goal of this study was to characterize local tumor control (LC), overall survival (OS), and safety of stereotactic radiosurgery for colorectal brain metastasis (CRBM). METHODS Ten international institutions participating in the International Radiosurgery Research Foundation provided data for this retrospective case series. This study included 187 patients with CRBM (281 tumors), with a median age of 62 years and 56.7% being male. Most patients (53.5%) had solitary tumors, although 10.7% had > 5 tumors. The median tumor volume was 2.7 cm3 (IQR 0.22–8.1 cm3), and the median margin dose was 20 Gy (IQR 18–22 Gy). RESULTS The 3-year LC and OS rates were 72% and 20%, respectively. Symptomatic adverse radiation effects occurred in 1.6% of patients. In the multivariate analysis, age > 65 years and tumor volume > 4.0 cm3 were significant predictors of tumor progression (hazard ratio [HR] 2.6, 95% CI 1.4–4.9; p = 0.003 and HR 3.4, 95% CI 1.7–6.9; p < 0.001, respectively). Better performance status (Karnofsky Performance Scale score > 80) was associated with a reduced risk of tumor progression (HR 0.38, 95% CI 0.19–0.73; p = 0.004). Patient age > 62 years (HR 1.6, 95% CI 1.1–2.3; p = 0.03) and the presence of active extracranial disease (HR 1.7, 95% CI 1.1–2.4; p = 0.009) were significantly associated with worse OS. CONCLUSIONS Stereotactic radiosurgery offers a high LC rate and a low rate of symptomatic adverse radiation effects for the majority of CRBMs. The OS and LC favored younger patients with high functional performance scores and inactive extracranial disease. https://thejns.org/doi/abs/10.3171/2023.8.JNS231231
KW - Gamma Knife radiosurgery
KW - brain metastasis
KW - colorectal cancer
KW - local tumor control
KW - oncology
KW - overall survival
KW - stereotactic radiosurgery
KW - tumor
UR - http://www.scopus.com/inward/record.url?scp=85192112804&partnerID=8YFLogxK
U2 - 10.3171/2023.8.JNS231231
DO - 10.3171/2023.8.JNS231231
M3 - Article
C2 - 37948682
AN - SCOPUS:85192112804
SN - 0022-3085
VL - 140
SP - 1233
EP - 1242
JO - Journal of Neurosurgery
JF - Journal of Neurosurgery
IS - 5
ER -